Publications

Cost and Outcomes of Paediatric Antiretroviral Treatment in South Africa

Gesine Meyer-Rath, Alana Brennan, Lawrence Long, Buyiswa Ndibongo, Karl Technau, Harry Moultrie, Lee Fairlie, Ashraf Coovadia and Sydney Rosen

AIDS 2012. 2013 Jan; 14(27):243-250.

Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South Africa

Gesine Meyer-Rath, Alana T. Brennan, Matthew P. Fox, Tebogo Modisenyane, Nkeko Tshabangu, Lerato Mohapi, Sydney Rosen, and Neil Martinson

JAIDS. 2013 Jan; 62(3):322-328.

Costs of Inpatient Treatment for Multi-Drug Resistant Tuberculosis in South Africa

Kathryn Schnippel, Sydney Rosen, Kate Shearer, Neil Martinson, Lawrence Long, Ian Sanne and Ebrahim Variava

Tropical Medicine and International Health. 2012 Dec;.

Cost and Resource Use of Patients on Antiretroviral Therapy in the Urban and Semiurban Public Sectors of South Africa

Gesine Meyer-Rath, MD, Alec Miners, PhD, Andreia C. Santos, PhD, Ebrahim Variava, MD, and Willem Daniel Francois Venter, MD

JAIDS. 2012 Nov; 61(3):25-32.

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere PimaTM Analyzer in South Africa

Bruce Larson, Kathryn Schnippel, Buyiswa Ndibongo, Lawrence Long, Matthew P. Fox, & Sydney Rosen

PLoS ONE. 2012 Apr; 7(4):1-8.

Costs and Cost-Effectiveness of Training Traditional Birth Attendants to Reduce Neonatal Mortality in the Lufwanyama Neonatal Survival Study (LUNESP)

Lora L. Sabin, Anna B. Knapp, William B. MacLeod, Grace Phiri-Mazala, Joshua Kasimba, Davidson H. Hamer & Christopher J. Gill

PLoS ONE. 2012 Apr; 7(4):1-10.

Cohort Profile: The Themba Lethu Clinical Cohort, Johannesburg, South Africa

Matthew P Fox, Mhairi Maskew, A Patrick MacPhail, Lawrence Long, Alana T Brennan, Daniel Westreich, William B MacLeod, Pappie Majuba & Ian M Sanne

International Journal of Epidemiology. 2012 Mar; 10(1093):1-10.

Cash Transfers In An Epidemic Context: The Interaction of Formal and Informal Support in Rural Malawi

Strobbe F., Miller C.

The World Bank, 1818 H Street, NW, Washington, DC 20433: The World Bank: Africa Region. Finance and Private Sector Developement Unit; 2011 Oct.

The Net Cost of Incorporating Resistance Testing into HIV/AIDS Treatment in South Africa: A Markov Model with Primary Data

Sydney R., Long L., Sanne I., Stevens W., Fox M.P.

Journal of International AIDS Society. 2011 Jul; 14(24):1-6.

Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort

Long L., Brennan A., Fox M.P., Ndibongo B., Jaffray I., Sanne I., Rosen S.

PLOS Medicine. 2011 Jul; 8(7):1-10.

The Incremental Cost Of Introducing Xpert® MTB/RIF into the South African National Tuberculosis Programme

Meyer-Rath G., Bistline K., Long L., MacLeod W., Sanne I., Stevens W., Rosen S.

Johannesburg, South Africa; Boston, MA: Health Economics and Epidemiology Research Office, Wits Health Consortium, University of the Witwatersrand (HE2RO); 2011 Jul.

Costing of OVC Service Delivery in South Africa and Zambia

Larson B., Hamazakaza P., Costello J., Laurence S.

Washington, DC: US Agency for International Development; 2011.